See other companies on Welcome to the Jungle

Invitae

Expert genetic insights

Invitae logo
1001+ employees
  • Healthcare
  • B2C
  • B2B
  • Biology
  • Data Sharing
  • MedTech
Design District, San Francisco, CA

Company mission

To bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

Top investors

-35% employee growth in 12 months

Our take

Invitae is a medical genetics company that is focused on bringing comprehensive genetic information into mainstream medicine, to improve healthcare for all people at any stage of their life. Its platform is made for providers and patients, with the ability to customize genetic tests in just a few clicks, and flexible pricing that ensures the service is widely accessible.

Despite being lauded for its low selling prices and high testing volume - which makes clinical-grade genetic testing available to the masses - Invitae has received criticism for the way it has been managed. This resulted in a strategic restructuring of the company in 2022, which deprioritised the company's focus on growth, so it could focus on becoming a more sustainable business. In 2024, it listed itself as bankrupt and through a sale, was purchased by Labcorp.

Despite this tumult, Invitae's new home at Labcorp means the company can still extend its platform. Further development of Invitae will be fueled by a range of investments in the form of convertible debt due in 2028 and share exchanges.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • Comprehensive benefits, including health, dental, and vision
  • Equity Options
  • Flexible working hours and opportunities to work from home
  • Generous vacation days ("take all the time you need; don't let your team down") and an excellent family leave policy

Company values

  • Team above the individual
  • Radically honest communication
  • Freedom with accountability
  • Transparency and data-informed action
  • A sense of urgency

Funding (last 2 of 5 rounds)

Oct 2014

$120m

SERIES F

Dec 2013

$40m

SERIES E

Total funding: $195.5m

This company has top investors

Leadership

Kenneth Knight

(CEO, not founder)

Previously worked at Amazon as Vice President, leading Middle Mile operations. Initially served as COO at Invitae, becoming CEO in 2022.